newsfilter
← Latest News
GlobeNewswire·

NextCure Announces Acceptance of IND Application for LNCB74

BELTSVILLE, Md., Dec. 10, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to